These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 19173265

  • 1. Dopamine D(2/3) receptor occupancy of apomorphine in the nonhuman primate brain--a comparative PET study with [11C]raclopride and [11C]MNPA.
    Finnema SJ, Halldin C, Bang-Andersen B, Gulyás B, Bundgaard C, Wikström HV, Farde L.
    Synapse; 2009 May; 63(5):378-89. PubMed ID: 19173265
    [Abstract] [Full Text] [Related]

  • 2. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
    Seneca N, Finnema SJ, Farde L, Gulyás B, Wikström HV, Halldin C, Innis RB.
    Synapse; 2006 Apr; 59(5):260-9. PubMed ID: 16416444
    [Abstract] [Full Text] [Related]

  • 3. Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA.
    Seneca N, Zoghbi SS, Skinbjerg M, Liow JS, Hong J, Sibley DR, Pike VW, Halldin C, Innis RB.
    Synapse; 2008 Oct; 62(10):756-63. PubMed ID: 18651641
    [Abstract] [Full Text] [Related]

  • 4. Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine.
    Kodaka F, Ito H, Takano H, Takahashi H, Arakawa R, Miyoshi M, Okumura M, Otsuka T, Nakayama K, Halldin C, Farde L, Suhara T.
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):83-9. PubMed ID: 20860881
    [Abstract] [Full Text] [Related]

  • 5. A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.
    Finnema SJ, Seneca N, Farde L, Shchukin E, Sóvágó J, Gulyás B, Wikström HV, Innis RB, Neumeyer JL, Halldin C.
    Nucl Med Biol; 2005 May; 32(4):353-60. PubMed ID: 15878504
    [Abstract] [Full Text] [Related]

  • 6. (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.
    Finnema SJ, Stepanov V, Nakao R, Sromek AW, Zhang T, Neumeyer JL, George SR, Seeman P, Stabin MG, Jonsson C, Farde L, Halldin C.
    J Nucl Med; 2014 Jul; 55(7):1164-70. PubMed ID: 24790219
    [Abstract] [Full Text] [Related]

  • 7. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T, Zysk J, Dorff P, Elmore CS, Ström P, Malmquist J, Ding M, Tuke D, Werkheiser J, Widzowski D, Mrzljak L, Maier D.
    Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of stress on [¹¹C]raclopride and [¹¹C]MNPA binding to striatal D₂/D₃ dopamine receptors: a PET study in conscious monkeys.
    Tsukada H, Ohba H, Nishiyama S, Kakiuchi T.
    Synapse; 2011 Jan; 65(1):84-9. PubMed ID: 20687105
    [Abstract] [Full Text] [Related]

  • 9. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
    Otsuka T, Ito H, Halldin C, Takahashi H, Takano H, Arakawa R, Okumura M, Kodaka F, Miyoshi M, Sekine M, Seki C, Nakao R, Suzuki K, Finnema S, Hirayasu Y, Suhara T, Farde L.
    J Nucl Med; 2009 May; 50(5):703-10. PubMed ID: 19372485
    [Abstract] [Full Text] [Related]

  • 10. Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride.
    Kodaka F, Ito H, Kimura Y, Fujie S, Takano H, Fujiwara H, Sasaki T, Nakayama K, Halldin C, Farde L, Suhara T.
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):574-9. PubMed ID: 23238524
    [Abstract] [Full Text] [Related]

  • 11. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R, Slifstein M, Guillin O, Hwang Y, Hwang DR, Scher E, Reeder S, Rabiner E, Laruelle M.
    Synapse; 2006 Dec 01; 60(7):485-95. PubMed ID: 16952157
    [Abstract] [Full Text] [Related]

  • 12. Measurement of the proportion of D2 receptors configured in state of high affinity for agonists in vivo: a positron emission tomography study using [11C]N-propyl-norapomorphine and [11C]raclopride in baboons.
    Narendran R, Hwang DR, Slifstein M, Hwang Y, Huang Y, Ekelund J, Guillin O, Scher E, Martinez D, Laruelle M.
    J Pharmacol Exp Ther; 2005 Oct 01; 315(1):80-90. PubMed ID: 16014571
    [Abstract] [Full Text] [Related]

  • 13. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N, Galineau L, Willeit M, Mizrahi R, Bloomfield PM, Seeman P, Houle S, Kapur S, Wilson AA.
    J Neurochem; 2006 May 01; 97(4):1089-103. PubMed ID: 16606355
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V, van Wieringen JP, Janssen HM, Fransen PM, Dierckx RA, Michel MC, Booij J, Elsinga PH.
    J Nucl Med; 2015 Jan 01; 56(1):133-9. PubMed ID: 25476538
    [Abstract] [Full Text] [Related]

  • 15. Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
    Kubota M, Nagashima T, Takano H, Kodaka F, Fujiwara H, Takahata K, Moriguchi S, Kimura Y, Higuchi M, Okubo Y, Takahashi H, Ito H, Suhara T.
    Int J Neuropsychopharmacol; 2017 Nov 01; 20(11):928-935. PubMed ID: 29016872
    [Abstract] [Full Text] [Related]

  • 16. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.
    Graff-Guerrero A, Willeit M, Ginovart N, Mamo D, Mizrahi R, Rusjan P, Vitcu I, Seeman P, Wilson AA, Kapur S.
    Hum Brain Mapp; 2008 Apr 01; 29(4):400-10. PubMed ID: 17497628
    [Abstract] [Full Text] [Related]

  • 17. Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates.
    Tóth M, Varrone A, Steiger C, Laszlovszky I, Horváth A, Kiss B, Gyertyán I, Adham N, Halldin C, Gulyás B.
    Synapse; 2013 May 01; 67(5):258-64. PubMed ID: 23238770
    [Abstract] [Full Text] [Related]

  • 18. Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study.
    Narendran R, Martinez D, Mason NS, Lopresti BJ, Himes ML, Chen CM, May MA, Price JC, Mathis CA, Frankle WG.
    Synapse; 2011 Dec 01; 65(12):1344-9. PubMed ID: 21780185
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.
    Skinbjerg M, Namkung Y, Halldin C, Innis RB, Sibley DR.
    Synapse; 2009 Jun 01; 63(6):462-75. PubMed ID: 19217026
    [Abstract] [Full Text] [Related]

  • 20. A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.
    Narendran R, Mason NS, Laymon CM, Lopresti BJ, Velasquez ND, May MA, Kendro S, Martinez D, Mathis CA, Frankle WG.
    J Pharmacol Exp Ther; 2010 May 01; 333(2):533-9. PubMed ID: 20103586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.